Gamifant (Emapalumab-lzsg)

Gamifant (Emapalumab-lzsg) is an interferon gamma (IFNγ)-blocking antibody used for the treatment of adult and pediatric (newborn and older) patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent, or progressive disease or intolerance with conventional hemophagocytic lymphohistiocytosis therapy.

Recommended Dosage: The recommended starting dose of Gamifant injection is 1 mg/kg given as an intravenous infusion over 1 hour twice per week (every 3 to 4 days). Doses subsequent to the initial dose may be increased depending on clinical and laboratory criteria.

Administer this IFNγ-blocking antibody until HSCT (Hematopoietic Stem Cell Transplantation) is performed or unacceptable toxicity. Discontinue treatment when a patient no longer requires therapy for the treatment of HLH. 

• Emapalumab-lzsg may increase the probability of fatal and serious infections to include specific pathogens favored by IFNγ neutralization, including Herpes Zoster virus, mycobacteria, and Histoplasma Capsulatum. Do not use Emapalumab-lzsg in those with infections caused by these pathogens until apt treatment has been started.
• Assess patients for tuberculosis risk factors and test for latent infection (PPD testing, PCR, or IFNγ release assay) prior to starting Emapalumab-lzsg. Use tuberculosis prophylaxis for tuberculosis or known to have a +Ve purified protein derivative (PPD) test result.
• Administer prophylaxis for Pneumocystis jirovecii, Herpes Zoster, and fungal infection to mitigate the probability to those while receiving Gamifant. Employ surveillance testing throughout therapy with Injection Gamifant.
• Closely monitor patients receiving Injection Emapalumab-lzsg for signs/symptoms of infection, promptly start a complete diagnostic workup apt for an immunocompromised patient, and start apt antimicrobial therapy.
• Avoid administering live or live attenuated vaccines to those receiving Emapalumab-lzsg and for a minimum of 4 weeks after the final dose of Emapalumab-lzsg. The safety of immunization with live vaccines throughout or following this therapy has not been evaluated.
• Infusion-related reactions including rash, drug eruption, pyrexia, erythema, and hyperhidrosis may occur in patients. All infusion related reactions can be mild to moderate. Evaluate those for infusion-related reactions. Interrupt infusion for infusion reactions and institute apt medical management before continuing infusion at a slower rate

What documents are required to import GAMIFANT to India?

GAMIFANT (Emapalumab-lzsg) Injection can be imported by patients or government hospitals on the name of the patients only. 

The following documentation required to import the product:

• Valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patients ID proof (issued by government of India)

How does order be confirmed?

The order will be confirmed only after the receipt of:

• Valid prescription of Doctor
• Import permit if applicable

Is GAMIFANT available in India?

GAMIFANT (Emapalumab-lzsg Injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input

• On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
• Medicine Price.
• Finding Genuine and reliable source from Canada, Europe, USA and Australia
• Ensuring 100% transparency.

GAMIFANT can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.

IPN (Indian Pharma Network) can facilitate the supply of GAMIFANT (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

Indian Pharma Network is able to source the GAMIFANT (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma Network offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Gamifant®?

Emapalumab-lzsg is Generic Name for the trade name drug Gamifant®.

What is the Manufacturer Name of Gamifant®?

Gamifant® is manufactured by Novimmune SA. 

Is Gamifant® approved by the FDA?

Yes, Gamifant® is approved by the FDA. Date of first/initial approval: November 20, 2018.

Where can I get Gamifant® at the best price in India?

To get the best Gamifant price in India, contact Indian Pharma Network (a WHO-GDP & ISO 9001:2008 authorized Company). A medical prescription is required while buying Gamifant®.

What is the dosage and form of Gamifant® supplied?

Gamifant® is supplied as Injections: 10 mg/2 mL (5mL mg/mL) and 50 mg/10 mL (5 mg/mL) solution in a single-dose vial for intravenous administration. 

What are the most common side effects with Gamifant®? 

The most common side effects with Gamifant® include: infections, hypertension, infusion-related reactions, and pyrexia.

How much does Gamifant® cost in India?

Gamifant cost in India is less and reasonable. In order to procure this HLH medication authentically, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Gamifant®?

Store in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze or shake. This medicinal product contains no preservatives.

Is it safe to buy Gamifant® online from India? 

Yes, You can buy Gamifant 50 mg injection online from India at the best price from Indian Pharma Network if Gamifant® has not been approved or is not available in your country.

What are the Highlights of prescribing information for Gamifant®?

Click Here to download full Gamifant prescribing information.